Pulmatrix, Inc. (PULM)
Largest Insider Buys in Sector
PULM Stock Price History Chart
PULM Stock Performance
About Pulmatrix, Inc.
Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing Pulmazole, an inhaled anti-fungal drug for the treatment of allergic …
Insider Activity of Pulmatrix, Inc.
Over the last 12 months, insiders at Pulmatrix, Inc. have bought $0 and sold $0 worth of Pulmatrix, Inc. stock.
On average, over the past 5 years, insiders at Pulmatrix, Inc. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,150,000 shares for transaction amount of $224,608 was made by MCGUIRE TERRANCE () on 2018‑04‑03.
List of Insider Buy and Sell Transactions, Pulmatrix, Inc.
| 2018-04-03 | 1.15M 0.9862% | $0.20 | $224,608 | -22.17% | ||||
| 2018-04-03 | director | 1.15M 3.2822% | $0.65 | $747,500 | -22.17% | |||
| 2018-04-03 | director | 307,000 0.8762% | $0.65 | $199,550 | -22.17% | |||
| 2018-04-03 | director | 20,000 0.0571% | $0.65 | $13,000 | -22.17% | |||
| 2015-06-17 | Sale | 10 percent owner | 922,500 3.7852% | $2.75 | $2.54M | -66.53% | ||
| 2015-06-16 | Sale | 10 percent owner | 727,500 3.023% | $2.75 | $2M | -66.10% | ||
| 2015-06-16 | director | 72,750 0.7558% | $6.88 | $500,156 | -66.10% | |||
| 2015-06-16 | director | 38,805 0.4031% | $6.88 | $266,784 | -66.10% | |||
| 2015-06-16 | director | 36,375 0.3779% | $6.88 | $250,078 | -66.10% | |||
| 2015-06-15 | 74,036 0.7174% | $6.88 | $508,998 | -68.30% | ||||
| 2015-03-23 | Sale | 10 percent owner | 350,000 0.2347% | $2.75 | $962,500 | -51.06% |
Insider Historical Profitability
| MCGUIRE TERRANCE | 3468190 94.9593% | $6.06 | 2 | 0 | <0.0001% | |
| GILLIS STEVEN | director | 3436456 94.0904% | $6.06 | 2 | 0 | <0.0001% |
| ROCKLAGE SCOTT M | director | 1192154 32.6413% | $6.06 | 1 | 0 | |
| Iwicki Mark T | director | 307000 8.4057% | $6.06 | 1 | 0 | <0.0001% |
| Maki David | director | 218194 5.9742% | $6.06 | 1 | 0 |
Institutional Investor Ownership
| Renaissance Technologies | $201,000.00 | 3.14 | 114,820 | -2.13% | -$4,378.17 | <0.0001 | |
| BlackRock | $96,073.00 | 1.5 | 54,899 | <0.01% | -$1.75 | <0.0001 | |
| The Vanguard Group | $61,394.00 | 0.96 | 35,082 | 0% | +$0 | <0.0001 | |
| Geode Capital Management | $41,203.00 | 0.68 | 24,660 | 0% | +$0 | <0.0001 | |
| State Street | $23,288.00 | 0.38 | 13,945 | 0% | +$0 | <0.0001 |